Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

BYD - A (002594.SZ)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rmb)	Price Target (Rmb)	Rating
2021-12-31	268.12	101.00	Sell
2022-01-21	250.40	326.00	Buy
2022-07-06	336.10	-	No Rating
2022-07-12	309.00	326.00	Buy
2022-08-11	315.02	370.00	Buy
2023-01-31	285.80	380.00	Buy
2023-09-04	252.45	390.00	Buy
2023-10-31	238.54	400.00	Buy
2024-08-29	234.85	366.00	Buy
2025-02-17	348.50	468.00	Buy

Disclosures

UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
Market capitalisation is calculated by multiplying the current share price by the sum of A and H shares.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.